Antibody response to GroEL varies in patients with acute Mycoplasma pneumoniae infection

Dusan Bencina1, Brigita Slavec, Mojca Narat

  • 1Department of Animal Sciences, Biotechnical Faculty, University of Ljubljana, 1230 Domzale, Slovenia.

Insights

Mycoplasma pneumoniae expresses abundant GroEL, a heat-shock protein. However, systemic antibodies against GroEL are rare in patients with M. pneumoniae respiratory infections, unlike antibodies to the P1 adhesin.

Area of Science:

  • Microbiology
  • Immunology
  • Molecular Biology

Background:

  • Heat-shock proteins are significant antigens in bacterial infections.
  • The immunogenicity of heat-shock proteins in Mycoplasma pneumoniae infections is not well understood.
  • Mycoplasma pneumoniae is a key pathogen causing human respiratory illness.

Purpose of the Study:

  • To investigate the synthesis and immunogenicity of the GroEL protein in Mycoplasma pneumoniae.
  • To determine the prevalence of antibodies against GroEL in patients with M. pneumoniae respiratory disease.

Main Methods:

  • Utilized a specific monoclonal antibody (2C2/C3) to detect GroEL synthesis.
  • Performed immunoblot analyses on patient sera to assess antibody responses.
  • Examined reference strains and clinical isolates of M. pneumoniae.

Main Results:

  • Abundant synthesis of ~58 kDa GroEL was confirmed in M. pneumoniae strains and clinical isolates.
  • Low prevalence of systemic antibodies against GroEL was observed in patients with M. pneumoniae respiratory disease (17.2%).
  • Antibody response to the P1 adhesin was strong in all patients, contrasting with the GroEL response.

Conclusions:

  • Mycoplasma pneumoniae actively synthesizes GroEL.
  • The GroEL protein of M. pneumoniae appears to have low immunogenicity in the context of acute respiratory infections.
  • Further research is needed to understand the role of GroEL immunity in M. pneumoniae pathogenesis.